Charles Crow
Internal Medicine · Birmingham, ALNPI 1356338842
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 225 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,390 and has fallen 98.7% since, to $18 in 2023.
Across 225 payments — averaging $14.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$591
- Pfizer$429
- AbbVie$282
- Boehringer Ingelheim$266
- Merck$231
- AstraZeneca$179
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,339100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 41 | $591 |
| Pfizer | 28 | $429 |
| AbbVie(2 entities) | 17 | $282 |
| Boehringer Ingelheim | 19 | $266 |
| Merck | 19 | $231 |
| AstraZeneca | 13 | $179 |
| Amgen | 11 | $172 |
| Amarin Pharma, Inc. | 11 | $172 |
| GSK | 12 | $166 |
| Sanofi-aventis U.S. LLC | 9 | $160 |
| Lilly USA, LLC | 8 | $105 |
| Astellas Pharma US Inc | 7 | $104 |
| Genentech USA, Inc. | 4 | $69 |
| Bayer | 3 | $51 |
| E.r. Squibb & Sons, L.L.C. | 3 | $42 |
| Boston Scientific | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 3 | $36 |
| Dexcom, Inc. | 2 | $33 |
| Mylan Specialty L.p. | 2 | $30 |
| Shire North American Group Inc | 2 | $30 |
| Abbott | 1 | $24 |
| Johnson & Johnson | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Grifols USA, LLC | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,339 in reported general payments places this provider in the 80th percentile of 1,533 internal medicine providers in Alabama.
Other internal medicine in Birmingham
- Ryan WeldonBirmingham$458K
- Robert LewisBirmingham$187K
- Thomas HuddleBirmingham$76K
- Jose VargasBirmingham$49K
- Donna FicoBirmingham$46K
- James SullivanBirmingham$39K
- Ross SchumacherBirmingham$26K
- Larry AlfordBirmingham$25K
- David WynneBirmingham$22K
- James CrenshawBirmingham$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.